BRIEF published on 11/06/2025 at 13:05, 1 month 14 days ago Moderna annonce un chiffre d'affaires d'un milliard de dollars au troisième trimestre 2025, malgré des prévisions financières revues à la baisse pour 2025. Résultats Financiers Moderna Baisse Des Revenus Vaccin Contre Le Covid-19 Efficacité En Matière De Coûts
PRESS RELEASE published on 11/06/2025 at 13:00, 1 month 14 days ago Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF published on 11/03/2025 at 13:05, 1 month 17 days ago Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
BRIEF published on 11/03/2025 at 13:05, 1 month 17 days ago Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
PRESS RELEASE published on 11/03/2025 at 13:00, 1 month 17 days ago Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 10/23/2025 at 20:47, 1 month 27 days ago Moderna Recognized as Top Employer for Eleventh Year in a Row Innovation Moderna MRNA Top Employer MNEXSPIKE
BRIEF published on 10/23/2025 at 20:47, 1 month 27 days ago Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
PRESS RELEASE published on 10/23/2025 at 20:42, 1 month 27 days ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
BRIEF published on 10/23/2025 at 13:05, 1 month 28 days ago Moderna organise un événement pour les investisseurs le 20 novembre 2025 Webcast Moderne Événement Pour Les Investisseurs Technologie De L'ARNm Journée Des Analystes
BRIEF published on 10/23/2025 at 13:05, 1 month 28 days ago Moderna to Host Investor Event on November 20, 2025 Webcast MRNA Technology Moderna Investor Event Analyst Day
Published on 12/20/2025 at 00:30, 16 hours 30 minutes ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 19 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 22 hours 30 minutes ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 1 day 2 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 1 day 3 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/20/2025 at 16:45, 15 minutes ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 6 hours 55 minutes ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 18 hours 57 minutes ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 19 hours 20 minutes ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 20 hours 25 minutes ago Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 21:57, 19 hours 3 minutes ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 1 day 8 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 1 day 8 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 1 day 10 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 1 day 10 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
